Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

NCT00151034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Urologic Neoplasms

Interventions

DRUG: Trastuzumab
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Gemcitabine

Sponsor

University of Michigan Rogel Cancer Center

Collaborators

[object Object]